Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tss (TSSI) Shares Outstanding (Diluted Average) (2016 - 2024)

Tss has reported Shares Outstanding (Diluted Average) over the past 13 years, most recently at $24.7 million for Q3 2024.

  • Quarterly Shares Outstanding (Diluted Average) rose 13.44% to $24.7 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $24.7 million through Sep 2024, up 13.44% year-over-year, with the annual reading at $22.0 million for FY2023, 9.77% up from the prior year.
  • Shares Outstanding (Diluted Average) was $24.7 million for Q3 2024 at Tss, roughly flat from $24.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $24.7 million in Q2 2024 and troughed at $17.7 million in Q1 2020.
  • The 5-year median for Shares Outstanding (Diluted Average) is $21.0 million (2020), against an average of $21.1 million.
  • Year-over-year, Shares Outstanding (Diluted Average) grew 20.95% in 2020 and then fell 12.51% in 2021.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $21.0 million in 2020, then fell by 12.51% to $18.4 million in 2021, then increased by 9.25% to $20.1 million in 2022, then rose by 9.77% to $22.0 million in 2023, then increased by 12.08% to $24.7 million in 2024.
  • Per Business Quant, the three most recent readings for TSSI's Shares Outstanding (Diluted Average) are $24.7 million (Q3 2024), $24.7 million (Q2 2024), and $22.4 million (Q1 2024).